The pandemic year has turned the conventional way of developing vaccines on its head. Though immunisation worldwide is a paediatric medical event, the first Covid-19 shots developed were for people aged 18 years and above.
Work on paediatric versions of Covid-19 vaccine, however, is not far behind, according to vaccine manufacturers in the race. A leading vaccine maker, which is in the final leg of developing a Covid-19 vaccine, said: “Once the immunisation programme starts and one can observe the vaccines in use on a mass-scale, the safety of these investigational products would be established beyond doubt. It is around the middle of the next year, that one would plan to start clinical trials for children.”
“Work on paediatric vaccine candidates should